Venture Certified
| 연구개발유형 | 2020-01-16 ~ 2022-01-15 | 20200100536 | 2020-01-16 |
| 연구개발유형 | 2022-01-16 ~ 2025-01-15 | 20220210020065 | 2020-01-16 |
| 연구개발유형 | 2025-01-16 ~ 2028-01-15 | 20250121020001 | 2020-01-16 |
Revenue CAGR +14.6%
| Item | 2023 | 2022 |
|---|---|---|
| Revenue | 92B | 80B |
| Operating Profit | 4.8B | -3.4B |
| Net Profit | 2.9B | 0.2B |
| Total Assets | 120B | 120B |
| Total Liabilities | 98B | 99B |
| Total Equity | 22B | 21B |
Debt Ratio 444.9%: Exceeds 400%, financial soundness risk
▲ 14.6%
▲ 240.1%
▲ 222.3%
▼ 5.7%
▲ 1595.5%
| Name | Position | Role |
|---|---|---|
| 박명희 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 남양주시",
"ceo_name": "박명희",
"certificate": [
{
"cert_number": "20200100536",
"changes": "",
"disclosure_date": "2020-01-16",
"first_cert_date": "2020-01-16",
"no": "1",
"type": "연구개발유형",
"valid_period": "2020-01-16 ~ 2022-01-15"
},
{
"cert_number": "20220210020065",
"changes": "",
"disclosure_date": "2022-02-10",
"first_cert_date": "2020-01-16",
"no": "2",
"type": "연구개발유형",
"valid_period": "2022-01-16 ~ 2025-01-15"
},
{
"cert_number": "20250121020001",
"changes": "",
"disclosure_date": "2025-01-21",
"first_cert_date": "2020-01-16",
"no": "3",
"type": "연구개발유형",
"valid_period": "2025-01-16 ~ 2028-01-15"
}
],
"company_name": "중앙생명연구원 주식회사",
"corp_no": "284111-*******",
"financials": {
"2022": {
"capital_stock": 1500000000,
"cost_of_sales": 0,
"current_assets": 1688808000,
"current_liabilities": 1304612000,
"gross_profit": 8016313000,
"net_income": 16356000,
"net_income_bs": 15385000,
"non_current_assets": 10267876000,
"non_current_liabilities": 8561516000,
"non_operating_expenses": 327943000,
"non_operating_income": 687450000,
"operating_profit": -343151000,
"revenue": 8016313000,
"sga_expenses": 8359464000,
"total_assets": 11956684000,
"total_equity": 2090556000,
"total_liabilities": 9866127000
},
"2023": {
"capital_stock": 1500000000,
"cost_of_sales": 0,
"current_assets": 1635299000,
"current_liabilities": 1150812000,
"gross_profit": 9184807000,
"net_income": 291405000,
"net_income_bs": 265821000,
"non_current_assets": 10333749000,
"non_current_liabilities": 8621503000,
"non_operating_expenses": 483431000,
"non_operating_income": 293913000,
"operating_profit": 480923000,
"revenue": 9184807000,
"sga_expenses": 8703884000,
"total_assets": 11969048000,
"total_equity": 2196733000,
"total_liabilities": 9772315000
}
},
"industry": "물질성분 검사 및 분석업",
"investment": [],
"main_products": "물질분석서비스",
"phone": "031-844-****",
"years": [
2023,
2022
]
}Data Quality: 7/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |